Study to Evaluate the Safety and Tolerability of EP0042

NCT04581512 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia
Chronic Myelomonocytic Leukemia
Myelodysplastic Syndromes

Interventions

DRUG: EP0042
DRUG: Venetoclax
DRUG: Azacitidine (AZA)

Sponsor

Ellipses Pharma